Adding adjuvant chemotherapy to radiotherapy did not lead to a significant survival benefit over radiotherapy alone in women ...

Current guidelines lack consensus and rely on lower-quality evidence, according to the author of new research.

The addition of concurrent cisplatin to adjuvant radiation therapy conferred no benefit to women with intermediate-risk, ...

Results from the NRG Oncology GOG-0263 Phase III clinical trial testing the addition of cisplatin-based chemotherapy to ...

Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian ...

Adjuvant CRT did not improve outcomes over adjuvant RT in patients with intermediate-risk, early-stage cervical cancer after radical hysterectomy.

Among women aged 20 to 24 years who were screened for cervical cancer, rates decreased by 79, 80 percent for CIN2+, CIN3+.

A consultant gynaecologist who recommended Ann Summers products to an elderly patient with vaginal bleeding, but who failed to carry out a thorough medical examination of the woman that might have ...

From April 25 to 30, 2025, the American Association for Cancer Research (AACR) Annual Meeting will take place in Chicago. CStone will showcase its latest preclinical studies on five internally ...